Precision oncology: East meets West

Vivek Subbiah¹, Jordi Rodon^{1

2}, Timothy A Yap^{1

2

3

4}

Affiliations

¹ Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ The Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX.

Editorial

Vivek Subbiah et al. Int J Cancer. 2018.

. 2018 May 1;142(9):1734-1737.

doi: 10.1002/ijc.31218. Epub 2018 Jan 4.

Vivek Subbiah¹, Jordi Rodon^{1

2}, Timothy A Yap^{1

2

3

4}

¹ Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ The Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

Keywords: next generation sequencing; precision oncology; targeted therapy.

Publication types